Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4804 Target Snapshot

M-phase inducer phosphatase 2 · SINGLE PROTEIN · Homo sapiens

858Compounds
162Assays
1Approved Drugs
763.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P30305. Use UniProt P30305 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P30305 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats M-phase inducer phosphatase 2 as ChEMBL target CHEMBL4804, mapped to UniProt P30305. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
M-phase inducer phosphatase 2
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4804
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P30305
M-phase inducer phosphatase 2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether M-phase inducer phosphatase 2 is the right protein anchor across sources, using UniProt P30305 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelM-phase inducer phosphatase 2
UniProt AccessionP30305
Component TypeProtein
Sequence Length580 aa

M-phase inducer phosphatase 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as M-phase inducer phosphatase 2, mapped to UniProt P30305. Sequence length is 580 aa.

Mapped IDP30305
Review nameM-phase inducer phosphatase 2
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50719.0
KI44.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5271462 7.28 IC50 53.0 Preclinical
CHEMBL5288122 7.28 IC50 53.0 Preclinical
CHEMBL476648 7.16 IC50 70.0 Preclinical
CHEMBL1481974 7.1 Ki 80.0 Preclinical
CHEMBL337173 7.02 Ki 95.0 Preclinical
CHEMBL1481974 7.0 IC50 100.0 Preclinical
CHEMBL429095 7.0 IC50 100.0 Preclinical
CHEMBL1095726 6.92 IC50 120.0 Preclinical
CHEMBL200117 6.92 IC50 120.0 Preclinical
CHEMBL1097720 6.8 IC50 160.0 Preclinical
Distribution

pChEMBL Value Distribution

202
5.0
107
5.5
47
6.0
21
6.5
9
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

166
Total Assays
583
Tested Compounds
1
Assay Types
Binding — 166 assays, 583 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 111 434 5.1
assay format 35 101 5.5
cell-based format 20 48 5.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine